Bain Capital Life Sciences Fund, L.P. insider trades: Annexon (ANNX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bain Capital Life Sciences Fund, L.P. reports to the SEC
and 1 more company
Open-market buys and sales
10 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 25, 2023 | ANNX | ↑ Buy | 300,000 | $2.13 | $640K | Indirect | May 30, 2023 (5d) |
| Jul 19, 2021 | RPID | ↑ Buy | 100,000 | $20.00 | $2.0M | Indirect | Jul 21, 2021 (2d) |
| Oct 26, 2020 | APTX | ↑ Buy | 3,333,333 | $3.00 | $10.0M | Indirect | Oct 27, 2020 (1d) |
| Jul 28, 2020 | ANNX | ↑ Buy | 400,000 | $17.00 | $6.8M | Indirect | Jul 28, 2020 (0d) |
| Feb 4, 2020 | ARQT | ↑ Buy | 294,117 | $17.00 | $5.0M | Indirect | Feb 6, 2020 (2d) |
| Nov 19, 2019 | DRNA | ↓ Sell | 1,750,000 | $22.03 | $38.6M | Indirect | Nov 21, 2019 (2d) |
| May 29, 2019 | DRNA | ↓ Sell | 1,600,000 | $12.50 | $20.0M | Indirect | May 31, 2019 (2d) |
| Jul 24, 2018 | REPL | ↑ Buy | 500,000 | $15.00 | $7.5M | Indirect | Jul 26, 2018 (2d) |
| Dec 19, 2017 | MRNS | ↓ Sell | 1,272,547 | $7.88 | $10.0M | Indirect | Dec 19, 2017 (0d) |
| Dec 18, 2017 | DRNA | ↑ Buy | 285,000 | $7.00 | $2.0M | Indirect | Dec 19, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANNX insiders
Open-market trades in the last 12 months
About Bain Capital Life Sciences Fund, L.P.'s insider trades
Bain Capital Life Sciences Fund, L.P. is a 10% owner of Annexon (ANNX). Since Dec 18, 2017, it has reported 7 open-market purchases worth $33.9M and 3 sales worth $68.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (4 filings), other transactions (1 filing), option exercises (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.